← Evidence map

ReviewEClinicalMedicine2026

Pharmacological considerations for prescribing of small molecule inhibitors in patients with non-small cell lung cancer.

Lotte M G Hulskotte et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 42775005